iBio

iBio

IBIO· Manufacturing· Fiscal year ends in June

CEO pay in FY2025Stock -63.8% in FY2025

Dr. Martin B. Brenner is the CEO of iBio and was paid $1.5M in FY2025 (Jun), up 19%.

Pay$100 in the stock at the end of FY21 → $1
CEO pay is from each iBio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Dr. Martin B. BrennerFY2025
  2. 2Felipe DuranFY2025
  3. 3Marc BanjakFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

iBio paid its 3 named executives $3.0M in total in FY2025 (Jun). CEO Dr. Martin B. Brenner was paid $1.5M of that.

Name
Dr. Martin B. BrennerChief Executive Officer and Chief Scientific OfficerNot disclosed
Felipe DuranChief Financial Officer
Marc BanjakChief Legal OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2024 (Jun) proxy of iBio names 16 peer companies for pay. Among iBio and these peers, CEO pay was the lowest of 5 and total shareholder return was the lowest of 5.

5th highest of 5in iBio and its pay peers, FY2024 (Jun) by CEO pay:

$1.3M$4.9M

5th highest of 5in iBio and its pay peers, FY2024 (Jun) by total shareholder return:

$2$102

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board5

See all
  • William D. ClarkChair · 4 yr on the boardIndependentAudit—Paid as an executive
  • Gary SenderDirector · 5 yr on the boardIndependentAudit (Chair), Compensation (Chair)—Paid as an executive
  • Evert SchimmelpenninkDirector · 4 yr on the boardIndependentCompensation—Paid as an executive
  • David ArkowitzDirector · 1 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
  • Dr. Martin B. BrennerDirector · 1 yr on the boardNot independent—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

Filings6

See all
Proxy statementDEF 14AOct 6, 2025FY2025
Annual report10-KSep 5, 2025FY2025
Proxy statementDEF 14AOct 10, 2024FY2024
Annual report10-KSep 20, 2024FY2024
Proxy statementDEF 14AOct 26, 2023FY2023
Annual report10-KSep 27, 2023FY2023
For the press:Download CSVDownload PNGHow to use our data